Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-573-90.
Published January 23, 2019 · Recall initiated: December 31, 2018
Summary
FDA records drug Class II recall D-0370-2019, published January 23, 2019 and initiated December 31, 2018. Recalling firm: Aurobindo Pharma USA Inc.; Status: Ongoing; Reported quantity: 20,604 bottles; Lot: Lot # VUSD17008-A, exp. date 07/2019 Lot # VUSD17009-A, exp. date 09/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
What to do
Voluntary: Firm initiated · Press Release
Get an email if VALSARTAN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VALSARTAN
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.
- Lot
- Lot # VUSD17008-A, exp. date 07/2019 Lot # VUSD17009-A, exp. date 09/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAValsartan Tablets USP 40 mg, 30 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJMarch 27, 2019
- FDAAmlodipine and Valsartan Tablets USP 10 mg/320 mg. 30-count bottles, Rx Only, Manufactured for: AurobindoJanuary 23, 2019
- FDAcuraplex Epi Safe Administration and Training Kits # 8600-01100. Kit contains 2 Epi Safe Administration KitJanuary 23, 2019
- FDAValsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAValsartan Tablets, USP, 320 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAValsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
Questions about this recall
Was Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-573-90. recalled?
Yes. FDA published recall D-0370-2019 on January 23, 2019. Reported hazard: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VALSARTAN.